ARCUTIS BIOTHERAPEUTICSCS INC
ARCUTIS BIOTHERAPEUTICSCS INC
Share · US03969K1088 · ARQT (XNAS)
Overview Financial Indicators
13,43 USD
-0,52 % -0,07 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
13.06.2025 23:56

Current Prices from ARCUTIS BIOTHERAPEUTICSCS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ARQT
USD
13.06.2025 23:56
13,43 USD
13,50 USD
-0,52 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -6,54 % -2,82 % -9,32 % 5,83 % 43,79 % -47,40 %

Company Profile for ARCUTIS BIOTHERAPEUTICSCS INC Share

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Invested Funds

The following funds have invested in: ARCUTIS BIOTHERAPEUTICSCS INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
37,61
Percentage (%)
0,09 %

Company Data

Name ARCUTIS BIOTHERAPEUTICSCS INC
Company Arcutis Biotherapeutics, Inc.
Symbol ARQT
Website https://www.arcutis.com
Primary Exchange XNAS NASDAQ
ISIN US03969K1088
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Todd Franklin Watanabe M.A.
Market Capitalization 2 Mrd.
Country United States of America
Currency USD
Employees 0,3 T
Address 3027 Townsgate Road, 91361 Westlake Village
IPO Date 2020-01-31

Ticker Symbols

Name Symbol
NASDAQ ARQT

More Shares

Investors who ARCUTIS BIOTHERAPEUTICSCS INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BIOGEN INC
BIOGEN INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EBAY INC
EBAY INC Share
INTEL CORP
INTEL CORP Share
KENTUCKY FIRST FEDERAL BANCORP
KENTUCKY FIRST FEDERAL BANCORP Share
M+G(L)I1-G.E.M DLAA
M+G(L)I1-G.E.M DLAA Fund
MICROSOFT CORP
MICROSOFT CORP Share
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Share
STRATIS
STRATIS Crypto
TEREGA 15/25
TEREGA 15/25 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025